Larry A. Greenbaum

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.5K citations · Full text

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

Christoph Licht, Larry A. Greenbaum, Petra Muus et al. · Kidney International · 2015 · 406 citations · Full text

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach

Crystal A. Gadegbeku, Debbie S. Gipson, Lawrence B. Holzman et al. · Kidney International · 2013 · 345 citations · Full text

Glomerular Disease, Multidisciplinary Approach, Renal Pathology +18

Management of Childhood Onset Nephrotic Syndrome

Debbie S. Gipson, Susan F. Massengill, Lynne Yao et al. · PEDIATRICS · 2009 · 303 citations

Glomerular Disease, Glomerulonephritis, Renal Disease +13

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Larry A. Greenbaum, Marc Fila, Gianluigi Ardissino et al. · Kidney International · 2016 · 286 citations · Full text